Lynx1 Capital Management as of March 31, 2022
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 14 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 21.9 | $24M | 894k | 26.44 | |
| Bellus Health Com New | 18.2 | $20M | 2.9M | 6.88 | |
| Alpine Immune Sciences (ALPN) | 12.4 | $13M | 1.5M | 8.97 | |
| Pardes Biosciences | 11.0 | $12M | 1.6M | 7.22 | |
| Travere Therapeutics (TVTX) | 9.9 | $11M | 412k | 25.77 | |
| Kinnate Biopharma (KNTE) | 7.2 | $7.8M | 693k | 11.26 | |
| ImmunoGen | 6.8 | $7.3M | 1.5M | 4.76 | |
| Cymabay Therapeutics | 4.0 | $4.3M | 1.4M | 3.11 | |
| Theseus Pharmaceuticals | 3.8 | $4.1M | 357k | 11.53 | |
| Pieris Pharmaceuticals (PIRS) | 3.2 | $3.4M | 1.1M | 3.03 | |
| Aerovate Therapeutics (AVTE) | 1.1 | $1.2M | 67k | 18.33 | |
| Passage Bio (PASG) | 0.3 | $327k | 106k | 3.10 | |
| Otonomy | 0.1 | $72k | 30k | 2.40 | |
| Elevation Oncology (ELEV) | 0.0 | $25k | 10k | 2.50 |
